OBJECTIVE: The genetic contributions to the multifactorial disorder osteoarthritis (OA) have been increasingly recognized. The goal of the current study was to use OA-related biomarkers of severity and disease burden as quantitative traits to identify genetic susceptibility loci for OA. METHODS: In a large multigenerational extended family (n = 350), we measured 5 OA-related biomarkers: hyaluronan (HA), cartilage oligomeric matrix protein (COMP), N-propeptide of type IIA collagen (PIIANP), C-propeptide of type II procollagen (CPII), and type II collagen neoepitope (C2C). Single-nucleotide polymorphism markers (n = 6,090) covering the whole genome were genotyped using the Illumina HumanLinkage-12 BeadChip. Variance components analysis, as implemented in the Sequential Oligogenic Linkage Analysis Routines, was used to estimate heritabilities of the quantitative traits and to calculate 2-point and multipoint logarithm of odds (LOD) scores using a polygenic model. RESULTS: After adjusting for age and sex, we found that 4 of the 5 biomarkers exhibited significant heritability (PIIANP 0.57, HA 0.49, COMP 0.43, C2C 0.30; P < or = 0.01 for all). Fourteen of the 19 loci that had multipoint LOD scores of >1.5 were near to or overlapped with previously reported OA susceptibility loci. Four of these loci were identified by more than 1 biomarker. The maximum multipoint LOD scores for the heritable quantitative biomarker traits were 4.3 for PIIANP (chromosome 8p23.2), 3.2 for COMP (chromosome 8q11.1), 2.0 for HA (chromosome 6q16.3), and 2.0 for C2C (chromosome 5q31.2). CONCLUSION: Herein, we report the first evidence of genetic susceptibility loci identified by OA-related biomarkers in an extended family. Our results demonstrate that serum concentrations of PIIANP, HA, COMP, and C2C have substantial heritable components, and using these biomarkers, several genetic loci potentially contributing to the genetic diversity of OA were identified.
OBJECTIVE: The genetic contributions to the multifactorial disorder osteoarthritis (OA) have been increasingly recognized. The goal of the current study was to use OA-related biomarkers of severity and disease burden as quantitative traits to identify genetic susceptibility loci for OA. METHODS: In a large multigenerational extended family (n = 350), we measured 5 OA-related biomarkers: hyaluronan (HA), cartilage oligomeric matrix protein (COMP), N-propeptide of type IIA collagen (PIIANP), C-propeptide of type II procollagen (CPII), and type II collagen neoepitope (C2C). Single-nucleotide polymorphism markers (n = 6,090) covering the whole genome were genotyped using the Illumina HumanLinkage-12 BeadChip. Variance components analysis, as implemented in the Sequential Oligogenic Linkage Analysis Routines, was used to estimate heritabilities of the quantitative traits and to calculate 2-point and multipoint logarithm of odds (LOD) scores using a polygenic model. RESULTS: After adjusting for age and sex, we found that 4 of the 5 biomarkers exhibited significant heritability (PIIANP 0.57, HA 0.49, COMP 0.43, C2C 0.30; P < or = 0.01 for all). Fourteen of the 19 loci that had multipoint LOD scores of >1.5 were near to or overlapped with previously reported OA susceptibility loci. Four of these loci were identified by more than 1 biomarker. The maximum multipoint LOD scores for the heritable quantitative biomarker traits were 4.3 for PIIANP (chromosome 8p23.2), 3.2 for COMP (chromosome 8q11.1), 2.0 for HA (chromosome 6q16.3), and 2.0 for C2C (chromosome 5q31.2). CONCLUSION: Herein, we report the first evidence of genetic susceptibility loci identified by OA-related biomarkers in an extended family. Our results demonstrate that serum concentrations of PIIANP, HA, COMP, and C2C have substantial heritable components, and using these biomarkers, several genetic loci potentially contributing to the genetic diversity of OA were identified.
Authors: T Ingvarsson; S E Stefánsson; J R Gulcher; H H Jónsson; H Jónsson; M L Frigge; E Pálsdóttir; G Olafsdóttir; T Jónsdóttir; G B Walters; L S Lohmander; K Stefánsson Journal: Arthritis Rheum Date: 2001-11
Authors: T Ikeda; A Mabuchi; A Fukuda; H Hiraoka; A Kawakami; S Yamamoto; H Machida; Y Takatori; H Kawaguchi; K Nakamura; S Ikegawa Journal: J Hum Genet Date: 2001 Impact factor: 3.172
Authors: V Vilím; R Vytásek; M Olejárová; S Machácek; J Gatterová; B Procházka; V B Kraus; K Pavelka Journal: Osteoarthritis Cartilage Date: 2001-10 Impact factor: 6.576
Authors: J Leppävuori; U Kujala; J Kinnunen; J Kaprio; M Nissilä; M Heliövaara; N Klinger; J Partanen; J D Terwilliger; L Peltonen Journal: Am J Hum Genet Date: 1999-10 Impact factor: 11.025
Authors: Joanne M Jordan; Gheorghe Luta; Thomas Stabler; Jordan B Renner; Anca D Dragomir; Vladimir Vilim; Marc C Hochberg; Charles G Helmick; Virginia B Kraus Journal: Arthritis Rheum Date: 2003-03
Authors: H-G Wisniewski; E Colón; V Liublinska; R J Karia; T V Stabler; M Attur; S B Abramson; P A Band; V B Kraus Journal: Osteoarthritis Cartilage Date: 2013-12-12 Impact factor: 6.576
Authors: Matlock A Jeffries; Madison Donica; Lyle W Baker; Michael E Stevenson; Anand C Annan; Mary Beth Humphrey; Judith A James; Amr H Sawalha Journal: Arthritis Rheumatol Date: 2016-06 Impact factor: 10.995
Authors: Stacey Knight; Ryan P Abo; Haley J Abel; Deborah W Neklason; Therese M Tuohy; Randall W Burt; Alun Thomas; Nicola J Camp Journal: Ann Hum Genet Date: 2012-09-19 Impact factor: 1.670
Authors: Hikmat N Daghestani; Joanne M Jordan; Jordan B Renner; Michael Doherty; A Gerry Wilson; Virginia B Kraus Journal: PLoS One Date: 2017-12-29 Impact factor: 3.240
Authors: Daniel Nolan; William E Kraus; Elizabeth Hauser; Yi-Ju Li; Dana K Thompson; Jessica Johnson; Hsiang-Cheng Chen; Sarah Nelson; Carol Haynes; Simon G Gregory; Virginia B Kraus; Svati H Shah Journal: PLoS One Date: 2013-08-02 Impact factor: 3.240
Authors: M Lotz; J Martel-Pelletier; C Christiansen; M-L Brandi; O Bruyère; R Chapurlat; J Collette; C Cooper; G Giacovelli; J A Kanis; M A Karsdal; V Kraus; W F Lems; I Meulenbelt; J-P Pelletier; J-P Raynauld; S Reiter-Niesert; R Rizzoli; L J Sandell; W E Van Spil; J-Y Reginster Journal: Postgrad Med J Date: 2014-03 Impact factor: 2.401
Authors: M Lotz; J Martel-Pelletier; C Christiansen; M-L Brandi; O Bruyère; R Chapurlat; J Collette; C Cooper; G Giacovelli; J A Kanis; M A Karsdal; V Kraus; W F Lems; I Meulenbelt; J-P Pelletier; J-P Raynauld; S Reiter-Niesert; R Rizzoli; L J Sandell; W E Van Spil; J-Y Reginster Journal: Ann Rheum Dis Date: 2013-07-29 Impact factor: 19.103